Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QBW251 interaction study with ethinyl estradiol/levonorgestrel oral contraceptive in healthy premenopausal women
NL-OMON40637Active, not recruiting
- Sponsor
- Novartis
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Icenticaftor, sponsored by Novartis. Primary endpoints: Pharmacokinetics of ethinyl estradiol and levonorgestrel with and without QBW251, Pharmacodynamics of oral contraceptive during QBW251 coadministration and 2 more. Started May 2015; status: active, not recruiting.
02
Drugs
Icenticaftor
Beyond the preview
Go deeper on NL-OMON40637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40637.